Anticancer vaccines usually cannot effectively eliminate tumours because persistent antigens convert tumour-specific effector CD8+ T cells into dysfunctional, even apoptotic, cells, thus leading to an ineffective immune response and hyporesponsiveness to subsequent vaccination42. The gene discussed is CD8A; the disease is neoplasm.